154 related articles for article (PubMed ID: 22347315)
1. Leishmania mexicana Gp63 cDNA Using Gene Gun Induced Higher Immunity to L. mexicana Infection Compared to Soluble Leishmania Antigen in BALB/C.
Rezvan H; Rees R; Ali S
Iran J Parasitol; 2011 Dec; 6(4):60-75. PubMed ID: 22347315
[TBL] [Abstract][Full Text] [Related]
2. CTL responses to Leishmania mexicana gp63-cDNA vaccine in a murine model.
Ali SA; Rezvan H; McArdle SE; Khodadadi A; Asteal FA; Rees RC
Parasite Immunol; 2009 Jul; 31(7):373-83. PubMed ID: 19527453
[TBL] [Abstract][Full Text] [Related]
3. CTL responses to DCs stimulated with leishmania antigens detected by DCs expressing Leishmania gp63.
Rezvan H; Khodadadi A; Ali SA
Iran J Immunol; 2014 Jun; 11(2):65-73. PubMed ID: 24975963
[TBL] [Abstract][Full Text] [Related]
4. Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.
Walker PS; Scharton-Kersten T; Rowton ED; Hengge U; Bouloc A; Udey MC; Vogel JC
Hum Gene Ther; 1998 Sep; 9(13):1899-907. PubMed ID: 9741428
[TBL] [Abstract][Full Text] [Related]
5. Leishmania mexicana gp63 is the enzyme responsible for cyclooxygenase (COX) activity in this parasitic protozoa.
Estrada-Figueroa LA; Díaz-Gandarilla JA; Hernández-Ramírez VI; Arrieta-González MM; Osorio-Trujillo C; Rosales-Encina JL; Toledo-Leyva A; Talamás-Rohana P
Biochimie; 2018 Aug; 151():73-84. PubMed ID: 29864507
[TBL] [Abstract][Full Text] [Related]
6. Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice.
Mazumder S; Maji M; Das A; Ali N
PLoS One; 2011 Feb; 6(2):e14644. PubMed ID: 21311597
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana.
González CR; Noriega FR; Huerta S; Santiago A; Vega M; Paniagua J; Ortiz-Navarrete V; Isibasi A; Levine MM
Vaccine; 1998; 16(9-10):1043-52. PubMed ID: 9682357
[TBL] [Abstract][Full Text] [Related]
8. gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.
Bhowmick S; Ravindran R; Ali N
Infect Immun; 2008 Mar; 76(3):1003-15. PubMed ID: 18195029
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of MHC Class I Peptides Derived from Leishmania mexicana Gp63 in HLA-A2.1 Transgenic (HHDII) and BALB/C Mouse Models.
Rezvan H; Rees R; Ali S
Iran J Parasitol; 2012; 7(4):27-40. PubMed ID: 23323089
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of DNA vaccines encoding various antigens against Leishmania mexicana.
Dumonteil E; Andrade-Narvarez F; Escobedo-Ortegon J; Ramirez-Sierra MJ; Valencia-Pacheco G; Flores-Serrano A; Canto-Lara S; Arjona-Torres A
Dev Biol (Basel); 2000; 104():135-41. PubMed ID: 11713811
[TBL] [Abstract][Full Text] [Related]
11. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63.
Connell ND; Medina-Acosta E; McMaster WR; Bloom BR; Russell DG
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11473-7. PubMed ID: 8265576
[TBL] [Abstract][Full Text] [Related]
12. Transcutaneous immunization using SLA or rLACK skews the immune response towards a Th1 profile but fails to protect BALB/c mice against a Leishmania major challenge.
Lakhal-Naouar I; Koles N; Rao M; Morrison EB; Childs JM; Alving CR; Aronson NE
Vaccine; 2019 Jan; 37(3):516-523. PubMed ID: 30528328
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccines induce partial protection against Leishmania mexicana.
Dumonteil E; Maria Jesus RS; Javier EO; Maria del Rosario GM
Vaccine; 2003 May; 21(17-18):2161-8. PubMed ID: 12706707
[TBL] [Abstract][Full Text] [Related]
14. Protection of C57BL/10 mice by vaccination with association of purified proteins from Leishmania (Leishmania) amazonensis.
Mora AM; Mayrink W; Costa RT; Costa CA; Genaro O; Nascimento E
Rev Inst Med Trop Sao Paulo; 1999; 41(4):243-8. PubMed ID: 10564919
[TBL] [Abstract][Full Text] [Related]
15. Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA).
Firouzmand H; Badiee A; Khamesipour A; Heravi Shargh V; Alavizadeh SH; Abbasi A; Jaafari MR
Acta Trop; 2013 Dec; 128(3):528-35. PubMed ID: 23916506
[TBL] [Abstract][Full Text] [Related]
16. Chitosan Nanoparticles Loaded with Whole and Soluble Leishmania Antigens, and Evaluation of Their Immunogenecity in a Mouse Model of Leishmaniasis.
Hojatizade M; Soleymani M; Tafaghodi M; Badiee A; Chavoshian O; Jaafari MR
Iran J Immunol; 2018 Dec; 15(4):281-293. PubMed ID: 30593742
[TBL] [Abstract][Full Text] [Related]
17. ISCOMs vaccine against experimental leishmaniasis.
Papadopoulou G; Karagouni E; Dotsika E
Vaccine; 1998; 16(9-10):885-92. PubMed ID: 9682333
[TBL] [Abstract][Full Text] [Related]
18. Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections.
Alexander J; Kaye PM
Clin Exp Immunol; 1985 Sep; 61(3):674-82. PubMed ID: 3907906
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory Effects of
Rezvan H; Ali SA; Hamoon Navard S
Iran J Parasitol; 2022; 17(4):562-572. PubMed ID: 36660416
[TBL] [Abstract][Full Text] [Related]
20. GK1 Improves the Immune Response Induced by Dendritic Cells of BALB/c Mice Infected with Leishmania mexicana Promastigotes.
Gutiérrez-Kobeh L; Wilkins-Rodríguez AA
Acta Parasitol; 2020 Mar; 65(1):27-35. PubMed ID: 31571138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
